In the United States, 75% of venture capital goes to software. Some 5 to 10% goes to biotech. The other sliver goes to everything else—transportation, sanitation, health care. No wonder the pandemic has exposed venture capital’s broader failures. https://t.co/N8FaQjJXGm— MIT Technology Review (@techreview) July 1, 2020
No comments:
Post a Comment